Pharma

Your Article Summary

See Latest Articles

Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
Amylin Pharmaceuticals, 11/02/09

Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited announced that they have entered into a worldwide exclusive license, development and commercialization agreement to co–develop and commercialize pharmaceutical products for the treatment of obesity and related indications.

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09

Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09

Harris Corp. Buys VA Contractor
HealthDataManagement, 11/23/09

 See all of M&A/Partnerships